KEWAUNEE SCIENTIFIC CP (KEQU) Fundamental Analysis & Valuation

NASDAQ:KEQU • US4928541048

Current stock price

36.11 USD
-0.89 (-2.41%)
Last:

This KEQU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. KEQU Profitability Analysis

1.1 Basic Checks

  • KEQU had positive earnings in the past year.
  • In the past year KEQU had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
  • In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • The Return On Assets of KEQU (6.30%) is better than 83.42% of its industry peers.
  • KEQU's Return On Equity of 15.68% is amongst the best of the industry. KEQU outperforms 89.84% of its industry peers.
  • The Return On Invested Capital of KEQU (12.17%) is better than 93.05% of its industry peers.
  • KEQU had an Average Return On Invested Capital over the past 3 years of 9.90%. This is in line with the industry average of 9.12%.
  • The last Return On Invested Capital (12.17%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.3%
ROE 15.68%
ROIC 12.17%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • With a decent Profit Margin value of 3.85%, KEQU is doing good in the industry, outperforming 75.40% of the companies in the same industry.
  • KEQU has a Operating Margin of 6.95%. This is in the better half of the industry: KEQU outperforms 73.80% of its industry peers.
  • KEQU has a worse Gross Margin (28.93%) than 74.33% of its industry peers.
  • KEQU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.95%
PM (TTM) 3.85%
GM 28.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KEQU Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
  • KEQU has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for KEQU has been increased compared to 5 years ago.
  • Compared to 1 year ago, KEQU has a worse debt to assets ratio.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • KEQU has an Altman-Z score of 3.49. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
  • KEQU's Altman-Z score of 3.49 is fine compared to the rest of the industry. KEQU outperforms 71.12% of its industry peers.
  • KEQU has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as KEQU would need 2.61 years to pay back of all of its debts.
  • The Debt to FCF ratio of KEQU (2.61) is better than 82.89% of its industry peers.
  • KEQU has a Debt/Equity ratio of 0.62. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
  • KEQU's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. KEQU is outperformed by 65.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.61
Altman-Z 3.49
ROIC/WACC1.55
WACC7.83%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.12 indicates that KEQU has no problem at all paying its short term obligations.
  • KEQU's Current ratio of 2.12 is on the low side compared to the rest of the industry. KEQU is outperformed by 60.43% of its industry peers.
  • KEQU has a Quick Ratio of 1.45. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
  • KEQU has a Quick ratio of 1.45. This is in the lower half of the industry: KEQU underperforms 64.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.45
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. KEQU Growth Analysis

3.1 Past

  • KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.07%.
  • The Revenue has grown by 30.78% in the past year. This is a very strong growth!
  • Measured over the past years, KEQU shows a quite strong growth in Revenue. The Revenue has been growing by 10.27% on average per year.
EPS 1Y (TTM)-37.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.31%
Revenue 1Y (TTM)30.78%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%3.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. KEQU Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.52, which indicates a very decent valuation of KEQU.
  • Compared to the rest of the industry, the Price/Earnings ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 94.12% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. KEQU is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.52
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 97.86% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, KEQU is valued cheaply inside the industry as 98.93% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.44
EV/EBITDA 5.46
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KEQU Dividend Analysis

5.1 Amount

  • No dividends for KEQU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KEQU Fundamentals: All Metrics, Ratios and Statistics

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (4/23/2026, 8:22:29 PM)

36.11

-0.89 (-2.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)06-23
Inst Owners42.06%
Inst Owner Change1.92%
Ins Owners15.69%
Ins Owner Change-1.37%
Market Cap103.64M
Revenue(TTM)287.75M
Net Income(TTM)11.08M
Analysts82.86
Price TargetN/A
Short Float %1.84%
Short Ratio7.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.52
Fwd PE N/A
P/S 0.36
P/FCF 5.44
P/OCF 4.59
P/B 1.47
P/tB 2.5
EV/EBITDA 5.46
EPS(TTM)4.24
EY11.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.64
FCFY18.39%
OCF(TTM)7.87
OCFY21.79%
SpS100.26
BVpS24.63
TBVpS14.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number48.4692 (34.23%)
Profitability
Industry RankSector Rank
ROA 6.3%
ROE 15.68%
ROCE 15.73%
ROIC 12.17%
ROICexc 13%
ROICexgc 17.14%
OM 6.95%
PM (TTM) 3.85%
GM 28.93%
FCFM 6.62%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.61
Debt/EBITDA 1.67
Cap/Depr 55.94%
Cap/Sales 1.23%
Interest Coverage 4.36
Cash Conversion 85.86%
Profit Quality 171.98%
Current Ratio 2.12
Quick Ratio 1.45
Altman-Z 3.49
F-Score6
WACC7.83%
ROIC/WACC1.55
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.78%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%3.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.25%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y24.21%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


Can you provide the profitability details for KEWAUNEE SCIENTIFIC CP?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


What is the valuation of KEWAUNEE SCIENTIFIC CP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KEWAUNEE SCIENTIFIC CP (KEQU) is 8.52 and the Price/Book (PB) ratio is 1.47.